Gene · 8930
Papers1,380
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,380
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors. | Transl Vis Sci Technol | 2026 | 42788773 | PubTator, text mining | PubMed |
| Prognostic significance of DNA damage response-related markers in esophageal squamous cell carcinoma using machine learning approaches. | J Gastrointest Oncol | 2026 | 42703410 | PubTator, text mining | PubMed |
| Human PMS1-dependent non-canonical mismatch repair engages with MBD4 to repair methylated CpG deamination. | Nucleic Acids Res | 2026 | 42578366 | PubTator, text mining | PubMed |
| Impact of Multigene Panel Testing in High-Risk Uveal Melanoma Patients. | Pigment Cell Melanoma Res | 2026 | 42415513 | PubTator, text mining | PubMed |
| Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines. | Eur J Breast Health | 2026 | 42317085 | PubTator, text mining | PubMed |
| Mapping DNA glycosylase binding across lesion sequence contexts reveals extended sequence and structural recognition logic. | Nat Commun | 2026 | 42251035 | PubTator, text mining | PubMed |
| Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomas. | Fam Cancer | 2026 | 42101541 | PubTator, text mining | PubMed |
| Germline haploinsufficiency of MUTYH causes mutational signature SBS18 in multiple tumour types and specifically raises colorectal cancer risk. | NPJ Precis Oncol | 2026 | 42092060 | PubTator, text mining | PubMed |
| Prevalence of the Predisposing Gene MBD4 for Uveal Melanoma. | JAMA Ophthalmol | 2026 | 42060275 | PubTator, text mining | PubMed |
| Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants. | JCO Precis Oncol | 2026 | 41990296 | PubTator, text mining | PubMed |
| Case Report: CYLD cutaneous syndrome with malignant transformation to spiradenocarcinoma: cooperative effects of CYLD truncation and an MSH2 clamp-domain variant in an Ecuadorian patient. | Front Med (Lausanne) | 2026 | 41788709 | PubTator, text mining | PubMed |
| Motif-Centered Analyses Reveal Universal and Tissue-Specific Mutagenic Mechanisms Operating in the Human Body. | bioRxiv | 2026 | 41756945 | PubTator, text mining | PubMed |
| TUBB2A and TM4SF1 Methylation Define Prognostic Subgroups in Adult-Type Diffuse Glioma. | Cancers (Basel) | 2026 | 41749891 | PubTator, text mining | PubMed |
| Rare Germline Variants in CDKN2A-Negative Children and Adolescents With Cutaneous Melanoma. | Pigment Cell Melanoma Res | 2026 | 41673532 | PubTator, text mining | PubMed |
| Effects of thymidylate synthase inhibitors differ in genomic uracilation and mutagenic potential. | Life Sci Alliance | 2026 | 41651672 | PubTator, text mining | PubMed |
| Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State. | Invest Ophthalmol Vis Sci | 2026 | 41590605 | PubTator, text mining | PubMed |
| Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine. | Nucleic Acids Res | 2026 | 41556338 | PubTator, text mining | PubMed |
| The role of histone demethylase PHF2 as a tumour suppressor in hepatocellular carcinoma by regulating SRXN1. | Oncogenesis | 2026 | 41554700 | PubTator, text mining | PubMed |
| The role of cytosine modification symmetry in mammalian epigenome regulation. | Chem Sci | 2026 | 41536432 | PubTator, text mining | PubMed |
| Study on epigenetic regulatory mechanism of MBD4 with a germline loss-of-function mutation (rs140693) responsible for retinoblastoma chemoresistance via the cell cycle and apoptotic pathways. | Pharmacol Res | 2026 | 41534805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8930/papers